Takeda Pharmaceutical Company LimitedNovember 26, 2025

FDA 483 - Takeda Pharmaceutical Company Limited - November 26, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Takeda Pharmaceutical Company Limited

Record Details

BAXALTA US INC. in Round Lake, IL, was inspected regarding its Flexbumin manufacturing operations. The inspection revealed significant deficiencies in quality control, including inadequate investigations into false positive contamination recoveries and recurring particulate matter. The firm also lacked scientifically sound laboratory controls for cross-contamination and failed to follow written procedures for production, process controls, and equipment cleaning.

Company: Takeda Pharmaceutical Company Limited
Inspection Date: November 26, 2025
Product Type: Biologics
Office: Chicago District Office
People: Peng Zhou
Shafiq S. Ahadi (Investigator)

Open in Dashboard

ID · e314f461-7a2b-42e9-9181-710be64dee9c